659 related articles for article (PubMed ID: 8878397)
21. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
22. CTLA4ig induces long-term graft survival of allogeneic skin grafts and totally inhibits T-cell proliferation in LFA-1-deficient mice.
Malm H; Corbascio M; Osterholm C; Cowan S; Larsen CP; Pearson TC; Ekberg H
Transplantation; 2002 Jan; 73(2):293-7. PubMed ID: 11821746
[TBL] [Abstract][Full Text] [Related]
23. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
[TBL] [Abstract][Full Text] [Related]
24. The time course of CTLAIg effect on cardiac allograft rejection.
Bolling SF; Lin H; Turka LA
J Surg Res; 1996 Jun; 63(1):320-3. PubMed ID: 8661218
[TBL] [Abstract][Full Text] [Related]
25. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
26. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2.
Onodera K; Chandraker A; Volk HD; Ritter T; Lehmann M; Kato H; Sayegh MH; Kupiec-Weglinski JW
Transplantation; 1999 Jul; 68(2):288-93. PubMed ID: 10440403
[TBL] [Abstract][Full Text] [Related]
27. Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin.
Taub DD; Murphy WJ; Asai O; Fenton RG; Peltz G; Key ML; Turcovski-Corrales S; Longo DL
J Immunol; 1997 Mar; 158(6):2745-55. PubMed ID: 9058809
[TBL] [Abstract][Full Text] [Related]
28. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
[TBL] [Abstract][Full Text] [Related]
29. Role of the CTLA4 pathway in hyporesponsiveness induced by intratracheal delivery of alloantigen.
Shirasugi N; Akiyama Y; Aramaki O; Shibutani S; Matsumoto K; Bashuda H; Yagita H; Okumura K; Ikeda Y; Niimi M
Transplantation; 2003 May; 75(10):1636-9. PubMed ID: 12777848
[TBL] [Abstract][Full Text] [Related]
30. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
Azuma H; Chandraker A; Nadeau K; Hancock WW; Carpenter CB; Tilney NL; Sayegh MH
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12439-44. PubMed ID: 8901600
[TBL] [Abstract][Full Text] [Related]
31. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
[TBL] [Abstract][Full Text] [Related]
32. Co-stimulatory molecules in islet xenotransplantation: CTLA4Ig treatment in CD40 ligand-deficient mice.
Benda B; Ljunggren HG; Peach R; Sandberg JO; Korsgren O
Cell Transplant; 2002; 11(7):715-20. PubMed ID: 12518898
[TBL] [Abstract][Full Text] [Related]
33. Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts.
Glysing-Jensen T; Räisänen-Sokolowski A; Sayegh MH; Russell ME
Transplantation; 1997 Dec; 64(12):1641-5. PubMed ID: 9422395
[TBL] [Abstract][Full Text] [Related]
34. CD28-independent costimulation of T cells in alloimmune responses.
Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
[TBL] [Abstract][Full Text] [Related]
35. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.
Arpinati M; Terragna C; Chirumbolo G; Rizzi S; Urbini B; Re F; Tura S; Baccarani M; Rondelli D
Exp Hematol; 2003 Jan; 31(1):31-8. PubMed ID: 12543104
[TBL] [Abstract][Full Text] [Related]
36. Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses.
Haspot F; Villemain F; Laflamme G; Coulon F; Olive D; Tiollier J; Soulillou JP; Vanhove B
Blood; 2002 Mar; 99(6):2228-34. PubMed ID: 11877302
[TBL] [Abstract][Full Text] [Related]
37. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
[TBL] [Abstract][Full Text] [Related]
38. CD2 regulates responsiveness of activated T cells to interleukin 12.
Gollob JA; Li J; Reinherz EL; Ritz J
J Exp Med; 1995 Sep; 182(3):721-31. PubMed ID: 7544396
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses.
Blazevic V; Trubey CM; Shearer GM
J Clin Immunol; 2001 Jul; 21(4):293-302. PubMed ID: 11506200
[TBL] [Abstract][Full Text] [Related]
40. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Vallera DA
Blood; 1995 May; 85(9):2607-18. PubMed ID: 7537122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
